| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Stents | 56 | 2021 | 657 | 7.340 |
Why?
|
| Blood Vessel Prosthesis Implantation | 37 | 2021 | 186 | 6.160 |
Why?
|
| Endovascular Procedures | 27 | 2022 | 366 | 5.810 |
Why?
|
| Blood Vessel Prosthesis | 20 | 2021 | 182 | 4.450 |
Why?
|
| Aortic Aneurysm, Abdominal | 27 | 2021 | 139 | 3.780 |
Why?
|
| Carotid Stenosis | 16 | 2019 | 163 | 3.530 |
Why?
|
| Angioplasty, Balloon | 18 | 2019 | 110 | 3.360 |
Why?
|
| Peripheral Arterial Disease | 9 | 2021 | 83 | 3.350 |
Why?
|
| Angioplasty | 18 | 2016 | 118 | 3.210 |
Why?
|
| Vascular Surgical Procedures | 22 | 2020 | 168 | 3.000 |
Why?
|
| Ischemia | 12 | 2021 | 229 | 2.840 |
Why?
|
| Endarterectomy, Carotid | 15 | 2020 | 110 | 2.690 |
Why?
|
| Lower Extremity | 13 | 2022 | 153 | 2.390 |
Why?
|
| Iliac Artery | 9 | 2020 | 44 | 2.280 |
Why?
|
| Treatment Outcome | 76 | 2022 | 7029 | 2.020 |
Why?
|
| Arterial Occlusive Diseases | 9 | 2015 | 134 | 1.840 |
Why?
|
| Time Factors | 45 | 2021 | 4655 | 1.830 |
Why?
|
| Vascular Patency | 19 | 2021 | 122 | 1.750 |
Why?
|
| Vascular Diseases | 7 | 2020 | 94 | 1.670 |
Why?
|
| Endoleak | 7 | 2016 | 23 | 1.660 |
Why?
|
| Aortic Aneurysm, Thoracic | 12 | 2019 | 134 | 1.590 |
Why?
|
| Aneurysm | 8 | 2016 | 53 | 1.530 |
Why?
|
| Vena Cava, Inferior | 4 | 2015 | 41 | 1.400 |
Why?
|
| Device Removal | 4 | 2015 | 100 | 1.280 |
Why?
|
| Risk Factors | 36 | 2021 | 5731 | 1.250 |
Why?
|
| Subclavian Artery | 4 | 2022 | 30 | 1.230 |
Why?
|
| Femoral Artery | 7 | 2022 | 139 | 1.190 |
Why?
|
| Prosthesis Design | 17 | 2019 | 301 | 1.160 |
Why?
|
| Embolic Protection Devices | 4 | 2016 | 12 | 1.150 |
Why?
|
| Aortic Diseases | 4 | 2016 | 113 | 1.150 |
Why?
|
| Aged | 66 | 2021 | 14862 | 1.130 |
Why?
|
| Carotid Artery Diseases | 3 | 2020 | 83 | 1.100 |
Why?
|
| Postoperative Complications | 23 | 2020 | 1615 | 1.100 |
Why?
|
| Humans | 121 | 2022 | 68618 | 1.070 |
Why?
|
| Vascular Access Devices | 3 | 2021 | 21 | 1.060 |
Why?
|
| Aorta, Abdominal | 4 | 2020 | 97 | 1.060 |
Why?
|
| Retrospective Studies | 43 | 2021 | 7277 | 1.060 |
Why?
|
| Aortic Aneurysm | 6 | 2015 | 77 | 1.030 |
Why?
|
| Veins | 3 | 2017 | 68 | 1.020 |
Why?
|
| Risk Assessment | 23 | 2020 | 2007 | 1.020 |
Why?
|
| Cardiovascular Agents | 2 | 2019 | 82 | 0.990 |
Why?
|
| Aneurysm, False | 4 | 2022 | 60 | 0.980 |
Why?
|
| Aged, 80 and over | 31 | 2021 | 4848 | 0.950 |
Why?
|
| Aorta, Thoracic | 5 | 2016 | 211 | 0.930 |
Why?
|
| Limb Salvage | 7 | 2021 | 39 | 0.930 |
Why?
|
| Middle Aged | 60 | 2022 | 21147 | 0.920 |
Why?
|
| Thrombosis | 6 | 2021 | 218 | 0.910 |
Why?
|
| Reoperation | 16 | 2020 | 467 | 0.910 |
Why?
|
| Female | 76 | 2022 | 38074 | 0.900 |
Why?
|
| Popliteal Artery | 4 | 2019 | 40 | 0.890 |
Why?
|
| Coated Materials, Biocompatible | 3 | 2019 | 54 | 0.890 |
Why?
|
| Intracranial Embolism | 2 | 2016 | 25 | 0.870 |
Why?
|
| Venous Thrombosis | 4 | 2013 | 125 | 0.870 |
Why?
|
| Iliac Vein | 2 | 2014 | 10 | 0.860 |
Why?
|
| Male | 73 | 2021 | 37321 | 0.850 |
Why?
|
| Debridement | 2 | 2022 | 55 | 0.830 |
Why?
|
| Mesenteric Vascular Occlusion | 3 | 2016 | 20 | 0.820 |
Why?
|
| Prosthesis Failure | 5 | 2013 | 130 | 0.780 |
Why?
|
| Length of Stay | 12 | 2020 | 780 | 0.760 |
Why?
|
| Aortography | 13 | 2015 | 72 | 0.750 |
Why?
|
| Stroke | 13 | 2020 | 2163 | 0.740 |
Why?
|
| Prospective Studies | 20 | 2022 | 3705 | 0.730 |
Why?
|
| Tomography, X-Ray Computed | 25 | 2016 | 2324 | 0.720 |
Why?
|
| Endarterectomy | 1 | 2020 | 22 | 0.720 |
Why?
|
| Atherectomy | 3 | 2014 | 7 | 0.710 |
Why?
|
| Ohio | 14 | 2019 | 64 | 0.710 |
Why?
|
| Ultrasonography, Interventional | 7 | 2022 | 119 | 0.710 |
Why?
|
| Blood Coagulation | 1 | 2020 | 123 | 0.700 |
Why?
|
| Drainage | 1 | 2020 | 133 | 0.670 |
Why?
|
| Kaplan-Meier Estimate | 13 | 2016 | 536 | 0.660 |
Why?
|
| Carotid Artery, Internal | 5 | 2010 | 85 | 0.660 |
Why?
|
| Constriction, Pathologic | 9 | 2017 | 236 | 0.660 |
Why?
|
| Paclitaxel | 1 | 2019 | 140 | 0.660 |
Why?
|
| Mesenteric Ischemia | 2 | 2016 | 8 | 0.630 |
Why?
|
| Arteriovenous Shunt, Surgical | 3 | 2020 | 31 | 0.590 |
Why?
|
| Unnecessary Procedures | 1 | 2017 | 49 | 0.570 |
Why?
|
| Aorta | 4 | 2013 | 316 | 0.550 |
Why?
|
| Iliac Aneurysm | 2 | 2014 | 7 | 0.550 |
Why?
|
| Vascular System Injuries | 1 | 2016 | 20 | 0.540 |
Why?
|
| Prosthesis-Related Infections | 4 | 2014 | 70 | 0.540 |
Why?
|
| Vena Cava Filters | 1 | 2015 | 18 | 0.510 |
Why?
|
| Proportional Hazards Models | 10 | 2013 | 792 | 0.500 |
Why?
|
| Embolism, Paradoxical | 1 | 2014 | 6 | 0.490 |
Why?
|
| Embolization, Therapeutic | 4 | 2014 | 150 | 0.480 |
Why?
|
| Femoral Vein | 2 | 2012 | 15 | 0.480 |
Why?
|
| Regional Blood Flow | 6 | 2021 | 168 | 0.480 |
Why?
|
| Patient Selection | 6 | 2020 | 592 | 0.470 |
Why?
|
| Hospital Mortality | 8 | 2016 | 384 | 0.470 |
Why?
|
| Postthrombotic Syndrome | 1 | 2013 | 6 | 0.450 |
Why?
|
| Alloys | 1 | 2014 | 66 | 0.450 |
Why?
|
| Clinical Competence | 4 | 2020 | 657 | 0.430 |
Why?
|
| Angiography | 8 | 2013 | 194 | 0.430 |
Why?
|
| Intraoperative Complications | 2 | 2010 | 129 | 0.400 |
Why?
|
| Chronic Disease | 6 | 2021 | 1330 | 0.390 |
Why?
|
| Chi-Square Distribution | 7 | 2016 | 546 | 0.380 |
Why?
|
| Thrombolytic Therapy | 7 | 2011 | 233 | 0.380 |
Why?
|
| Foreign-Body Migration | 3 | 2011 | 38 | 0.380 |
Why?
|
| Erythrocyte Transfusion | 1 | 2011 | 72 | 0.380 |
Why?
|
| Upper Extremity | 1 | 2012 | 112 | 0.370 |
Why?
|
| Venous Insufficiency | 1 | 2011 | 27 | 0.370 |
Why?
|
| Diagnostic Errors | 1 | 2011 | 100 | 0.360 |
Why?
|
| Follow-Up Studies | 14 | 2015 | 3259 | 0.350 |
Why?
|
| Tibial Arteries | 3 | 2008 | 6 | 0.350 |
Why?
|
| Government Regulation | 2 | 2018 | 46 | 0.350 |
Why?
|
| Angioplasty, Laser | 2 | 2006 | 4 | 0.340 |
Why?
|
| Critical Care | 1 | 2012 | 263 | 0.340 |
Why?
|
| Peripheral Vascular Diseases | 4 | 2013 | 50 | 0.340 |
Why?
|
| Leg | 4 | 2008 | 191 | 0.330 |
Why?
|
| Carotid Artery, Common | 1 | 2008 | 25 | 0.320 |
Why?
|
| Laparotomy | 1 | 2008 | 65 | 0.320 |
Why?
|
| Cadaver | 1 | 2008 | 136 | 0.310 |
Why?
|
| Odds Ratio | 5 | 2016 | 880 | 0.300 |
Why?
|
| Cryopreservation | 1 | 2008 | 103 | 0.300 |
Why?
|
| Arteries | 4 | 2022 | 108 | 0.300 |
Why?
|
| Feasibility Studies | 5 | 2021 | 652 | 0.300 |
Why?
|
| Graft Occlusion, Vascular | 6 | 2013 | 73 | 0.290 |
Why?
|
| Severity of Illness Index | 9 | 2015 | 1851 | 0.280 |
Why?
|
| United States | 8 | 2021 | 7367 | 0.280 |
Why?
|
| Registries | 3 | 2020 | 733 | 0.270 |
Why?
|
| Health Policy | 1 | 2008 | 221 | 0.270 |
Why?
|
| Heart Injuries | 1 | 2006 | 25 | 0.270 |
Why?
|
| Treatment Failure | 3 | 2013 | 216 | 0.260 |
Why?
|
| Renal Dialysis | 2 | 2020 | 174 | 0.260 |
Why?
|
| Cause of Death | 2 | 2019 | 241 | 0.260 |
Why?
|
| Quality of Health Care | 1 | 2008 | 322 | 0.250 |
Why?
|
| Aneurysm, Infected | 2 | 2015 | 16 | 0.250 |
Why?
|
| Randomized Controlled Trials as Topic | 4 | 2019 | 931 | 0.250 |
Why?
|
| Adult | 20 | 2020 | 21403 | 0.230 |
Why?
|
| Workload | 2 | 2019 | 103 | 0.230 |
Why?
|
| Vascular Grafting | 3 | 2013 | 12 | 0.230 |
Why?
|
| Equipment Design | 4 | 2016 | 500 | 0.220 |
Why?
|
| Viscera | 3 | 2016 | 16 | 0.220 |
Why?
|
| Elective Surgical Procedures | 4 | 2013 | 95 | 0.220 |
Why?
|
| Chile | 2 | 2013 | 17 | 0.220 |
Why?
|
| New Zealand | 2 | 2013 | 28 | 0.220 |
Why?
|
| Brachial Artery | 3 | 2008 | 34 | 0.220 |
Why?
|
| Hypogastric Plexus | 1 | 2003 | 1 | 0.220 |
Why?
|
| Aneurysm, Ruptured | 4 | 2011 | 40 | 0.220 |
Why?
|
| Anticoagulants | 3 | 2017 | 356 | 0.210 |
Why?
|
| Platelet Aggregation Inhibitors | 2 | 2017 | 373 | 0.210 |
Why?
|
| Celiac Artery | 2 | 2015 | 12 | 0.210 |
Why?
|
| Blood Pressure | 5 | 2016 | 1451 | 0.210 |
Why?
|
| Ferredoxin-NADP Reductase | 1 | 2022 | 3 | 0.200 |
Why?
|
| Arabidopsis Proteins | 1 | 2022 | 13 | 0.200 |
Why?
|
| Multicenter Studies as Topic | 2 | 2021 | 186 | 0.200 |
Why?
|
| Critical Illness | 3 | 2019 | 191 | 0.200 |
Why?
|
| Practice Guidelines as Topic | 3 | 2013 | 772 | 0.190 |
Why?
|
| Heart Ventricles | 1 | 2006 | 738 | 0.190 |
Why?
|
| Retreatment | 1 | 2021 | 59 | 0.190 |
Why?
|
| Phlebography | 2 | 2011 | 31 | 0.190 |
Why?
|
| Radiography, Interventional | 2 | 2013 | 49 | 0.190 |
Why?
|
| Survival Analysis | 9 | 2013 | 714 | 0.190 |
Why?
|
| Cerebrovascular Circulation | 2 | 2015 | 296 | 0.180 |
Why?
|
| Fibrinogen | 1 | 2020 | 87 | 0.180 |
Why?
|
| Renal Artery Obstruction | 3 | 2013 | 29 | 0.180 |
Why?
|
| Renal Artery | 3 | 2013 | 29 | 0.180 |
Why?
|
| Multivariate Analysis | 5 | 2016 | 1046 | 0.180 |
Why?
|
| Comorbidity | 6 | 2014 | 1426 | 0.170 |
Why?
|
| Databases, Factual | 3 | 2019 | 622 | 0.170 |
Why?
|
| Young Adult | 4 | 2017 | 5717 | 0.170 |
Why?
|
| Computed Tomography Angiography | 2 | 2022 | 424 | 0.170 |
Why?
|
| Postoperative Hemorrhage | 1 | 2020 | 69 | 0.170 |
Why?
|
| Catheterization, Central Venous | 1 | 2020 | 89 | 0.170 |
Why?
|
| Delivery of Health Care, Integrated | 1 | 2020 | 77 | 0.170 |
Why?
|
| Centralized Hospital Services | 1 | 2019 | 3 | 0.170 |
Why?
|
| Regional Health Planning | 1 | 2019 | 7 | 0.170 |
Why?
|
| Certification | 1 | 2020 | 66 | 0.170 |
Why?
|
| Hospitals, High-Volume | 1 | 2019 | 18 | 0.170 |
Why?
|
| Life Tables | 2 | 2010 | 29 | 0.170 |
Why?
|
| Quality Indicators, Health Care | 1 | 2020 | 136 | 0.160 |
Why?
|
| Prognosis | 4 | 2019 | 2093 | 0.160 |
Why?
|
| Echocardiography | 1 | 2022 | 515 | 0.160 |
Why?
|
| Reimbursement Mechanisms | 1 | 2018 | 37 | 0.160 |
Why?
|
| Logistic Models | 4 | 2016 | 1420 | 0.160 |
Why?
|
| Surgeons | 1 | 2019 | 68 | 0.150 |
Why?
|
| Recurrence | 4 | 2011 | 948 | 0.150 |
Why?
|
| Angiography, Digital Subtraction | 4 | 2013 | 63 | 0.150 |
Why?
|
| Evidence-Based Medicine | 2 | 2018 | 438 | 0.150 |
Why?
|
| Kidney Failure, Chronic | 1 | 2020 | 365 | 0.140 |
Why?
|
| Consensus | 3 | 2022 | 211 | 0.140 |
Why?
|
| Education, Medical, Graduate | 1 | 2019 | 214 | 0.140 |
Why?
|
| Preoperative Care | 2 | 2013 | 275 | 0.140 |
Why?
|
| Wound Healing | 2 | 2012 | 260 | 0.140 |
Why?
|
| Atherosclerosis | 2 | 2010 | 204 | 0.140 |
Why?
|
| Pressoreceptors | 1 | 2016 | 15 | 0.140 |
Why?
|
| Ankle | 2 | 2008 | 45 | 0.140 |
Why?
|
| Mesenteric Arteries | 2 | 2014 | 29 | 0.140 |
Why?
|
| Coronary Artery Disease | 1 | 2022 | 696 | 0.140 |
Why?
|
| Baroreflex | 1 | 2016 | 20 | 0.140 |
Why?
|
| Ultrasonography, Doppler, Duplex | 1 | 2016 | 25 | 0.140 |
Why?
|
| Viridans Streptococci | 1 | 2015 | 4 | 0.130 |
Why?
|
| Cardiac Surgical Procedures | 2 | 2013 | 450 | 0.130 |
Why?
|
| New Brunswick | 1 | 2015 | 1 | 0.130 |
Why?
|
| Ischemic Attack, Transient | 2 | 2010 | 167 | 0.130 |
Why?
|
| Electric Stimulation | 1 | 2016 | 218 | 0.130 |
Why?
|
| Peritoneum | 2 | 2006 | 27 | 0.130 |
Why?
|
| Endocarditis, Bacterial | 1 | 2015 | 32 | 0.130 |
Why?
|
| Boston | 1 | 2015 | 35 | 0.130 |
Why?
|
| Health Care Costs | 1 | 2018 | 346 | 0.130 |
Why?
|
| Streptococcal Infections | 1 | 2015 | 53 | 0.130 |
Why?
|
| Imaging, Three-Dimensional | 2 | 2008 | 333 | 0.130 |
Why?
|
| Neurologic Examination | 1 | 2015 | 107 | 0.130 |
Why?
|
| Perfusion | 1 | 2015 | 131 | 0.120 |
Why?
|
| Intermittent Claudication | 1 | 2015 | 31 | 0.120 |
Why?
|
| Adolescent | 5 | 2017 | 8912 | 0.120 |
Why?
|
| Retroperitoneal Fibrosis | 1 | 2014 | 5 | 0.120 |
Why?
|
| Aspergillus | 1 | 2014 | 8 | 0.120 |
Why?
|
| Endocarditis | 1 | 2014 | 14 | 0.120 |
Why?
|
| Foramen Ovale, Patent | 1 | 2014 | 21 | 0.120 |
Why?
|
| Aspergillosis | 1 | 2014 | 20 | 0.120 |
Why?
|
| Endoscopy | 2 | 2016 | 464 | 0.120 |
Why?
|
| Asymptomatic Diseases | 2 | 2015 | 43 | 0.120 |
Why?
|
| Radiography | 3 | 2014 | 572 | 0.120 |
Why?
|
| Cerebral Revascularization | 1 | 2014 | 45 | 0.120 |
Why?
|
| Carotid-Cavernous Sinus Fistula | 2 | 2005 | 5 | 0.120 |
Why?
|
| Ankle Brachial Index | 1 | 2014 | 10 | 0.120 |
Why?
|
| Acute Disease | 1 | 2016 | 658 | 0.120 |
Why?
|
| Fibromuscular Dysplasia | 1 | 2013 | 2 | 0.110 |
Why?
|
| Aortic Coarctation | 1 | 2013 | 37 | 0.110 |
Why?
|
| Emergencies | 1 | 2013 | 107 | 0.110 |
Why?
|
| Pilot Projects | 2 | 2019 | 1342 | 0.110 |
Why?
|
| Heart Valve Diseases | 1 | 2014 | 123 | 0.110 |
Why?
|
| Hypertension, Renovascular | 1 | 2013 | 47 | 0.110 |
Why?
|
| Cardiovascular Abnormalities | 1 | 2013 | 15 | 0.110 |
Why?
|
| Myocardial Infarction | 3 | 2019 | 807 | 0.110 |
Why?
|
| Diverticulum | 1 | 2013 | 29 | 0.110 |
Why?
|
| Intracranial Aneurysm | 1 | 2014 | 87 | 0.110 |
Why?
|
| Disease Progression | 2 | 2013 | 1038 | 0.110 |
Why?
|
| Vascular Malformations | 1 | 2013 | 19 | 0.110 |
Why?
|
| Europe | 1 | 2013 | 196 | 0.110 |
Why?
|
| Heart Valve Prosthesis | 1 | 2014 | 222 | 0.110 |
Why?
|
| Heart Valve Prosthesis Implantation | 1 | 2014 | 164 | 0.110 |
Why?
|
| Renal Insufficiency | 2 | 2005 | 121 | 0.110 |
Why?
|
| Equipment Safety | 3 | 2008 | 50 | 0.110 |
Why?
|
| Aortic Valve | 1 | 2014 | 249 | 0.100 |
Why?
|
| Cardiovascular Diseases | 1 | 2020 | 940 | 0.100 |
Why?
|
| Ischemic Postconditioning | 1 | 2012 | 2 | 0.100 |
Why?
|
| Vascular Calcification | 1 | 2014 | 131 | 0.100 |
Why?
|
| Aortic Valve Stenosis | 1 | 2014 | 177 | 0.100 |
Why?
|
| Age Factors | 4 | 2013 | 1864 | 0.100 |
Why?
|
| Thrombectomy | 3 | 2011 | 238 | 0.100 |
Why?
|
| Databases as Topic | 2 | 2009 | 49 | 0.100 |
Why?
|
| Disability Evaluation | 1 | 2014 | 298 | 0.100 |
Why?
|
| Brain Injuries | 1 | 2015 | 268 | 0.100 |
Why?
|
| Catheter-Related Infections | 1 | 2012 | 43 | 0.100 |
Why?
|
| Decision Support Techniques | 1 | 2013 | 191 | 0.100 |
Why?
|
| Coronary Disease | 1 | 2013 | 358 | 0.100 |
Why?
|
| Cerebrovascular Disorders | 1 | 2012 | 182 | 0.100 |
Why?
|
| Aortic Rupture | 1 | 2011 | 32 | 0.100 |
Why?
|
| Embolectomy | 1 | 2011 | 5 | 0.100 |
Why?
|
| Splenic Artery | 1 | 2011 | 16 | 0.090 |
Why?
|
| Filtration | 2 | 2008 | 61 | 0.090 |
Why?
|
| Intraoperative Period | 1 | 2011 | 62 | 0.090 |
Why?
|
| Watchful Waiting | 1 | 2011 | 25 | 0.090 |
Why?
|
| Collateral Circulation | 1 | 2010 | 34 | 0.090 |
Why?
|
| Embolism | 1 | 2011 | 45 | 0.090 |
Why?
|
| Clinical Trials as Topic | 4 | 2012 | 848 | 0.090 |
Why?
|
| Thrombophilia | 1 | 2010 | 21 | 0.090 |
Why?
|
| Chronic Pain | 1 | 2012 | 110 | 0.090 |
Why?
|
| Calcinosis | 2 | 2010 | 241 | 0.090 |
Why?
|
| Transplantation, Homologous | 2 | 2008 | 242 | 0.090 |
Why?
|
| Respiratory Insufficiency | 1 | 2011 | 76 | 0.090 |
Why?
|
| Carotid Arteries | 1 | 2010 | 110 | 0.090 |
Why?
|
| Radiodermatitis | 1 | 2009 | 8 | 0.080 |
Why?
|
| Drug Administration Schedule | 1 | 2010 | 567 | 0.080 |
Why?
|
| Deglutition Disorders | 1 | 2013 | 297 | 0.080 |
Why?
|
| Monitoring, Physiologic | 1 | 2010 | 219 | 0.080 |
Why?
|
| Neoplasms, Radiation-Induced | 1 | 2009 | 79 | 0.080 |
Why?
|
| Ultrasonography | 1 | 2010 | 453 | 0.080 |
Why?
|
| Patient Rights | 1 | 2008 | 11 | 0.080 |
Why?
|
| Polytetrafluoroethylene | 1 | 2008 | 55 | 0.080 |
Why?
|
| Balloon Occlusion | 1 | 2008 | 22 | 0.080 |
Why?
|
| Mesenteric Artery, Inferior | 1 | 2008 | 1 | 0.080 |
Why?
|
| Catheterization, Peripheral | 1 | 2008 | 38 | 0.080 |
Why?
|
| Credentialing | 1 | 2008 | 23 | 0.080 |
Why?
|
| Cardiovascular Surgical Procedures | 1 | 2008 | 36 | 0.080 |
Why?
|
| Mesenteric Artery, Superior | 1 | 2008 | 8 | 0.080 |
Why?
|
| Health Facilities | 1 | 2008 | 36 | 0.080 |
Why?
|
| Digestive System Surgical Procedures | 1 | 2008 | 30 | 0.080 |
Why?
|
| Acute Kidney Injury | 1 | 2011 | 232 | 0.080 |
Why?
|
| History, 21st Century | 1 | 2008 | 127 | 0.080 |
Why?
|
| Image Interpretation, Computer-Assisted | 2 | 2008 | 237 | 0.080 |
Why?
|
| Calcium Channel Blockers | 1 | 2008 | 138 | 0.070 |
Why?
|
| History, 20th Century | 1 | 2008 | 248 | 0.070 |
Why?
|
| Angiotensin-Converting Enzyme Inhibitors | 1 | 2008 | 202 | 0.070 |
Why?
|
| Arm | 1 | 2007 | 59 | 0.070 |
Why?
|
| Prostheses and Implants | 2 | 2005 | 159 | 0.070 |
Why?
|
| Edema | 1 | 2007 | 66 | 0.070 |
Why?
|
| Radiation Dosage | 1 | 2009 | 419 | 0.070 |
Why?
|
| Biomedical Research | 1 | 2010 | 310 | 0.070 |
Why?
|
| Extremities | 1 | 2006 | 49 | 0.070 |
Why?
|
| Survival Rate | 5 | 2010 | 1056 | 0.070 |
Why?
|
| Polyethylene Terephthalates | 1 | 2005 | 29 | 0.070 |
Why?
|
| Surveys and Questionnaires | 1 | 2014 | 2800 | 0.070 |
Why?
|
| Blood Flow Velocity | 1 | 2006 | 172 | 0.070 |
Why?
|
| Algorithms | 3 | 2006 | 1196 | 0.060 |
Why?
|
| Parasympatholytics | 1 | 2005 | 19 | 0.060 |
Why?
|
| Atropine | 1 | 2005 | 29 | 0.060 |
Why?
|
| Echocardiography, Transesophageal | 1 | 2006 | 100 | 0.060 |
Why?
|
| Bradycardia | 1 | 2005 | 45 | 0.060 |
Why?
|
| Pulmonary Disease, Chronic Obstructive | 1 | 2008 | 207 | 0.060 |
Why?
|
| Ultrasonography, Doppler, Color | 1 | 2005 | 21 | 0.060 |
Why?
|
| Predictive Value of Tests | 4 | 2015 | 1465 | 0.060 |
Why?
|
| Axillary Artery | 1 | 2004 | 6 | 0.060 |
Why?
|
| Reperfusion | 1 | 2005 | 78 | 0.060 |
Why?
|
| Hypotension | 1 | 2005 | 74 | 0.060 |
Why?
|
| Vascular Neoplasms | 1 | 2004 | 15 | 0.060 |
Why?
|
| Leiomyoma | 1 | 2004 | 28 | 0.060 |
Why?
|
| Single-Blind Method | 2 | 2015 | 249 | 0.060 |
Why?
|
| Compartment Syndromes | 1 | 2003 | 13 | 0.060 |
Why?
|
| Sex Factors | 4 | 2013 | 1266 | 0.060 |
Why?
|
| Animals | 4 | 2008 | 20881 | 0.060 |
Why?
|
| Carotid Artery, Internal, Dissection | 1 | 2003 | 9 | 0.050 |
Why?
|
| Hemodilution | 1 | 2003 | 9 | 0.050 |
Why?
|
| Blood Transfusion, Autologous | 1 | 2003 | 17 | 0.050 |
Why?
|
| Jehovah's Witnesses | 1 | 2003 | 5 | 0.050 |
Why?
|
| Smoking Cessation | 1 | 2012 | 1034 | 0.050 |
Why?
|
| Pain Management | 1 | 2005 | 186 | 0.050 |
Why?
|
| Diagnosis, Differential | 1 | 2006 | 1140 | 0.050 |
Why?
|
| Erythropoietin | 1 | 2003 | 96 | 0.050 |
Why?
|
| Saphenous Vein | 1 | 2002 | 61 | 0.050 |
Why?
|
| Disease-Free Survival | 2 | 2013 | 349 | 0.050 |
Why?
|
| Blood Loss, Surgical | 2 | 2016 | 79 | 0.050 |
Why?
|
| Clinical Decision-Making | 1 | 2020 | 109 | 0.040 |
Why?
|
| Patient-Centered Care | 1 | 2020 | 106 | 0.040 |
Why?
|
| Leg Ulcer | 1 | 2019 | 26 | 0.040 |
Why?
|
| Policy Making | 1 | 2018 | 51 | 0.040 |
Why?
|
| Calcium | 1 | 2022 | 929 | 0.040 |
Why?
|
| Patient Care Team | 1 | 2020 | 311 | 0.040 |
Why?
|
| Reproducibility of Results | 2 | 2015 | 2077 | 0.040 |
Why?
|
| Coronary Angiography | 1 | 2022 | 866 | 0.040 |
Why?
|
| Referral and Consultation | 1 | 2019 | 383 | 0.030 |
Why?
|
| Carotid Sinus | 1 | 2016 | 5 | 0.030 |
Why?
|
| Operative Time | 1 | 2016 | 45 | 0.030 |
Why?
|
| Catheters | 1 | 2016 | 39 | 0.030 |
Why?
|
| Ligation | 1 | 2015 | 83 | 0.030 |
Why?
|
| Tensile Strength | 2 | 2006 | 90 | 0.030 |
Why?
|
| Cytoprotection | 1 | 2015 | 39 | 0.030 |
Why?
|
| Recovery of Function | 1 | 2019 | 506 | 0.030 |
Why?
|
| Fluorescent Antibody Technique | 2 | 2006 | 282 | 0.030 |
Why?
|
| Curriculum | 1 | 2019 | 575 | 0.030 |
Why?
|
| Cohort Studies | 2 | 2013 | 2358 | 0.030 |
Why?
|
| Dogs | 2 | 2006 | 490 | 0.030 |
Why?
|
| Cattle | 2 | 2006 | 475 | 0.030 |
Why?
|
| Prednisone | 1 | 2014 | 104 | 0.030 |
Why?
|
| Materials Testing | 2 | 2006 | 263 | 0.030 |
Why?
|
| Heart Rate | 1 | 2016 | 568 | 0.030 |
Why?
|
| Analysis of Variance | 1 | 2016 | 1040 | 0.030 |
Why?
|
| Antifungal Agents | 1 | 2014 | 108 | 0.030 |
Why?
|
| Time | 1 | 2013 | 57 | 0.030 |
Why?
|
| Neuropsychological Tests | 1 | 2015 | 517 | 0.030 |
Why?
|
| Confidence Intervals | 1 | 2013 | 242 | 0.030 |
Why?
|
| Sternotomy | 1 | 2012 | 18 | 0.030 |
Why?
|
| Thoracotomy | 1 | 2012 | 25 | 0.030 |
Why?
|
| Nonlinear Dynamics | 1 | 2012 | 55 | 0.030 |
Why?
|
| Superior Vena Cava Syndrome | 1 | 2012 | 15 | 0.030 |
Why?
|
| Thoracic Outlet Syndrome | 1 | 2012 | 7 | 0.030 |
Why?
|
| APACHE | 1 | 2011 | 41 | 0.020 |
Why?
|
| Cognition | 1 | 2015 | 513 | 0.020 |
Why?
|
| Academic Medical Centers | 1 | 2013 | 281 | 0.020 |
Why?
|
| Cardiopulmonary Bypass | 1 | 2012 | 250 | 0.020 |
Why?
|
| Protective Devices | 1 | 2010 | 13 | 0.020 |
Why?
|
| Observation | 1 | 2010 | 30 | 0.020 |
Why?
|
| Meta-Analysis as Topic | 1 | 2010 | 57 | 0.020 |
Why?
|
| Ultrasonography, Doppler | 1 | 2010 | 57 | 0.020 |
Why?
|
| Probability | 1 | 2010 | 245 | 0.020 |
Why?
|
| Dose-Response Relationship, Radiation | 1 | 2009 | 84 | 0.020 |
Why?
|
| Observer Variation | 1 | 2010 | 330 | 0.020 |
Why?
|
| Hemostatic Techniques | 1 | 2008 | 23 | 0.020 |
Why?
|
| Radiation Monitoring | 1 | 2009 | 41 | 0.020 |
Why?
|
| Minimally Invasive Surgical Procedures | 1 | 2009 | 85 | 0.020 |
Why?
|
| Radiation Protection | 1 | 2009 | 71 | 0.020 |
Why?
|
| Hematoma | 1 | 2008 | 47 | 0.020 |
Why?
|
| Spinal Cord Ischemia | 1 | 2008 | 21 | 0.020 |
Why?
|
| Fluoroscopy | 1 | 2009 | 152 | 0.020 |
Why?
|
| Incidence | 1 | 2012 | 1603 | 0.020 |
Why?
|
| Hypolipidemic Agents | 1 | 2008 | 82 | 0.020 |
Why?
|
| Necrosis | 1 | 2008 | 239 | 0.020 |
Why?
|
| Enbucrilate | 1 | 2007 | 5 | 0.020 |
Why?
|
| Tissue Adhesives | 1 | 2007 | 17 | 0.020 |
Why?
|
| Hypertension | 1 | 2016 | 1535 | 0.020 |
Why?
|
| Physical Exertion | 1 | 2007 | 75 | 0.020 |
Why?
|
| Paraplegia | 1 | 2006 | 28 | 0.020 |
Why?
|
| Hemorrhage | 1 | 2008 | 328 | 0.020 |
Why?
|
| Syndrome | 1 | 2007 | 255 | 0.020 |
Why?
|
| Magnetic Resonance Imaging | 1 | 2015 | 2223 | 0.020 |
Why?
|
| Diabetes Mellitus | 1 | 2012 | 694 | 0.020 |
Why?
|
| Artifacts | 1 | 2007 | 125 | 0.020 |
Why?
|
| Tomography, Spiral Computed | 1 | 2006 | 57 | 0.020 |
Why?
|
| Carotid Artery, External | 1 | 2005 | 5 | 0.020 |
Why?
|
| Magnetic Resonance Angiography | 1 | 2005 | 181 | 0.010 |
Why?
|
| Forearm | 1 | 2003 | 25 | 0.010 |
Why?
|
| New York | 1 | 2004 | 223 | 0.010 |
Why?
|
| Heart Atria | 1 | 2004 | 206 | 0.010 |
Why?
|
| Skin Transplantation | 1 | 2003 | 45 | 0.010 |
Why?
|
| Neoplasm Invasiveness | 1 | 2004 | 369 | 0.010 |
Why?
|
| Continuity of Patient Care | 1 | 2004 | 170 | 0.010 |
Why?
|
| Constriction | 1 | 2002 | 37 | 0.010 |
Why?
|
| Anastomosis, Surgical | 1 | 2002 | 104 | 0.010 |
Why?
|
| Demography | 1 | 2002 | 279 | 0.010 |
Why?
|
| Terminology as Topic | 1 | 2002 | 141 | 0.010 |
Why?
|
| Smoking | 1 | 2008 | 1452 | 0.010 |
Why?
|
| Hemodynamics | 1 | 2002 | 705 | 0.010 |
Why?
|
| Antihypertensive Agents | 1 | 2002 | 498 | 0.010 |
Why?
|
| Research Design | 1 | 2002 | 729 | 0.010 |
Why?
|
| Kidney | 1 | 2002 | 945 | 0.010 |
Why?
|